# Genetics of QT Response to Moxifloxacin

> **NCT01936480** · PHASE4 · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 51 (actual)

## Conditions studied

- Cardiac Arrhythmias

## Interventions

- **DRUG:** Moxifloxacin 400mg once time

## Key facts

- **NCT ID:** NCT01936480
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-10
- **Primary completion:** 2019-06-19
- **Final completion:** 2019-06-19
- **Target enrollment:** 51 (ACTUAL)
- **Why stopped:** Recruitment difficulties
- **Last updated:** 2022-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01936480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01936480, "Genetics of QT Response to Moxifloxacin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01936480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*